skip to content

Verona Pharma

16:51 on 17/11/2017

Current Price 112.00p | Bid 112.00p | Ask 115.00p | Change 0.44%

Company Overview

Verona Pharma plc (formerly Isis Resources plc) is developing first-in-class drugs to treat respiratory disease, such as COPD and asthma. The Company currently has two drug programmes, one of which is in Phase II trials for two diseases. The lead programme, RPL554, is an innovative dual phosphodiesterase (PDE) 3 and 4 inhibitor with both bronchodilator and anti-inflammatory properties. In its second programme, Verona Pharma is investigating novel anti-inflammatory molecules, called NAIPs, for a wide range of respiratory and inflammatory diseases.

Stock Details

Shares in Issue 1,009,923,481
Market cap £ 31.31m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Financial Highlights Year Ended 31/12/2013

Turnover £0.00 million
Operating Profit £-2.82 million
Dividend Yield 0.00
Dividend Per Share 0.00
Dividend Cover 0.00
P/E Ratio -4.25
» More Financials

Key Personnel

Clive Page Chairman
Michael Walker CEO

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 113.50p
Bid Price ? 112.00p
Ask Price ? 115.00p
Volume ? 39873
Change Today 0.50p
% Change Today 0.44%
Open 112.60p
Previous Close 113.50p
Intraday High 112.90p
Intraday Low 107.90p
52 Week High 5.18p
52 Week Low 2.20p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.